.png/:/rs=h:96,cg:true,m/qt=q:95){kind=logo}
NOSE TO BRAIN DELIVERY
The Future of Central Nervous System
and Systemic Therapies
Addressing Unmet Clinical Needs
Through Compassionate Use Innovation
Kurve Therapeutics is pioneering a new era in the treatment of systemic and central nervous system disorders with our patented Nose‑to‑Brain technology.
What is the Vianase Platform
- Intranasal delivery platform designed to support exploration of investigational CNS and Longevity formulations
- Designated for controlled delivery to the upper nasal cavity for research purposes
- Utilized in qualified investigational research and Expanded Access (Compassionate Use for traditional & regenerative medicine)
- Investigational device intended for clinical research use only
Examples of Investigational Research Include
Alzheimer's
Parkinson's
PanS/pandas
traumatic brain injury
Lewy body dementia
Neurological Inflammation
Micro Concussions/ Concussions
Autism
MULTIPLE sclerosis
Patient Registry Link
Patients, families, and treating physicians seeking compassionate use access through the NFL Compassionate Use Registry may begin the secure intake process through the KurveResearch patient registry portal. The registry is designed to help collect patient information, document eligibility, support physician review, and assist with preparation of the required FDA Form 3926 for individual expanded access requests.
About Kurve Research
Our Mission
Kurve Research is dedicated to developing innovative treatments for CNS disorders. We focus on bypassing the blood-brain barrier challenges with our advanced Controlled Particle Dispersion® technology.
Our mission:
To put it simply: we do this because we can & because we should.
Our mission is to help as many people as we possibly can in their fight against systemic and neurodegenerative disorders. We believe that these complex and debilitating disorders may finally become manageable when the right medication is paired with the right technology. Our goal is to enhance the quality of life for patients and provide a solution where their past treatments have failed them–to give people a renewed sense of hope for the future.
Innovative Delivery
Our proprietary ViaNase™ platform uses Controlled Particle Dispersion® technology to deliver targeted, effective treatments bypassing the blood-brain barrier, reducing side effects and enhancing therapeutic impact. Discover how our innovative delivery systems are bridging the gap in neurotherapeutics.
Reduction in systemic side effects
Non-invasive / painless
Increased patient compliance
Innovative CNS Intranasal Delivery Platform
Kurve ViaNASE Intranasal Device
SPECIALIZED Nosepieces
You are required to obtain a prescription from a licensed physician in order to purchase this intranasal medical device. Please contact us by email for further information regarding the ordering process.